NICE (UK National Institute for Clinical Excellence): troponin test delays prompt PCI (percutaneous coronary intervention) policy review
This article was originally published in Clinica
Executive Summary
Delays in providing the results of cardiac troponin tests for patients being considered for percutaneous coronary intervention (PCI) has prompted the UK's National Institute for Clinical Excellence (NICE) to review its guidance on the use of drugs to reduce the risk of adverse cardiac events. The decision comes as the institute's Scottish counterpart - the Health Technology Board for Scotland - has begun to appraise troponin testing, with particular emphasis on point-of-care testing as a potential alternative (see page 5).